Chronic kidney disease in Japan from early predictions to current facts

Nephron - Clinical Practice

Volumn 110, Issue 4, 2008, Pages

  Iseki, Kunitoshi ^a  

^a UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

Author keywords

Asian Forum of CKD Initiative; Chronic kidney disease; CKD, incidence and prevalence; CKD, screening; End stage renal disease; Frontier of Renal Outcome Modifications in Japan; Japanese Society for Dialysis Therapy

Indexed keywords

ANTIBIOTIC AGENT; CONTRAST MEDIUM; NONSTEROID ANTIINFLAMMATORY AGENT;

CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIALYSIS; ENVIRONMENTAL FACTOR; GLOMERULUS FILTRATION RATE; HEREDITY; HUMAN; HYPERTENSION; JAPAN; KIDNEY FAILURE; METABOLIC SYNDROME X; MUSCLE MASS; NEPHRON; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SALT INTAKE; SCREENING; SHORT STATURE; SHORT SURVEY; SOCIAL ASPECT; SURVIVAL;

EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INCIDENCE; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; OUTCOME ASSESSMENT (HEALTH CARE); RISK ASSESSMENT; RISK FACTORS;

EID: 55449094956     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000170094     Document Type: Short Survey

References (20)

1. Levey AS, Atkins R, Coresh J, et al: Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007;72:247-259.
2. Sarnak MJ, Levey AS, Schoolwerth AC, et al: Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154-2169.
3. Go AS, Chertow GM, Fan D, et al: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305.
4. Nakai S, Wada A, Kitaoka T, et al: An overview of regular dialysis treatment in Japan (as of 31 December 2004). Ther Apher Dial 2006;10:476-497.
5. Iseki K: Chronic kidney disease in Japan. Int Med 2008;47:681-689.
6. Goodkin DA, Young EW, Kurokawa K, et al: Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis 2004;44(suppl 2):S16-S21.
7. Imai E, Yamagata K, Iseki K, et al: Kidney disease screening program in Japan, outcome and perspectives. Clin J Am Soc Nephrol 2007;2:1360-1366.
8. Imai E, Horio M, Yamagata K, et al: GFR decline rate in Japanese general population: a longitudinal 10 year follow-up study. Hypertens Res 2008;31:433-442.
9. Ninomiya T, Kiyohara Y: Chronic kidney disease and other diseases. 1. Cardiovascular diseases (in Japanese). Nippon Naika Gakkai Zasshi 2007;96:887-893.
10. Ninomiya T, Kiyohara Y, Kubo M, et al: Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis 2006;48:383-391.
11. Tozawa M, Iseki C, Tokashiki K, et al: Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 2007;30:937-943.
12. Yamagata K, Ishida K, Sairenchi T, et al: Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 2007;71:159-166.
13. Iseki K: The Okinawa screening program. J Am Soc Nephrol 2003;14(suppl 2):S127-S130.
14. Iseki K: Screening for renal disease - what can be learned from Okinawa experience? Nephrol Dial Transplant 2006;21:839-843.
15. Wen CP, Cheng TYD, Tsai MK, et al: All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462,293 adults in Taiwan. Lancet 2008;371:2173-2182.
16. Iseki K, Kinjo K, Iseki C, Takishita S: Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis 2004;44:806-814
17. Imai E, Matsuo S, Makino H, et al: Chronic kidney disease Japanese Cohort (CKD-JAC) study: design and methods. Hypertens Res 2008;31:1101-1108.
18. Sunagawa H, Iseki K, Nishime K, et al: Epidemiologic analysis of diabetic patients on chronic dialysis. Nephron 1996;74:361-366.
19. Makino H, Haneda M, Babazono T, et al: Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes. Diabetes Care 2007;30:1577-1578.
20. Araki S, Haneda M, Koya D, et al: Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes. Diabetes 2007;56:1727-1730.